RegenLab
En Budron B2
CH-1052 Le Mont-sur-Lausanne
Switzerland

T +41 21 864 38 00
F +41 21 864 38 01
E-mail info@regenlab.com
Current zone : us -
Technology

Regen Lab’s core competence is in understanding key areas including the:

  • requirements of aesthetic therapies and care
  • challenges in surgery
  • treatment of chronic wounds

Platelet rich plasma (PRP)PRP is developed from the patient’s own (autologous) blood. It is therefore inherently safe and free of risk from transmitted diseases such as HIV or hepatitis. The concentration of platelets within PRP delivers an increased number of growth factors in biologically determined ratios. This distinguishes PRP from recombinant (non-native) growth factors. Additionally, PRP is different to fibrin glues as it contains the same concentration of cell adhesion molecules as normal blood.